Non-small cell lung cancer Clinical Trials
Conditions / Non-small cell lung cancer
Delta Trials records 22 clinical trials for Non-small cell lung cancer in its publicly accessible dataset. From the full dataset, 16 actively seeking eligible participants and 0 trials have reached completion. This research is conducted across 657 study locations around the world. An additional 6 trials are active but not currently open for enrollment. Since 2020, 1 trial have been stopped, reflecting shifts in research priorities or feasibility. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.
Trial Status
22
Total Trials
16
Recruiting
0
Completed
6
Other Active
1
Terminated since 2020
657
Study Locations
Browse by location (657 total)
- Barcelona, Spain 10 trialsAll trials in Barcelona, Spain
- Beijing, China 10 trialsAll trials in Beijing, China
- Madrid, Spain 9 trialsAll trials in Madrid, Spain
- Seoul, South Korea 9 trialsAll trials in Seoul, South Korea
- Houston, United States 9 trialsAll trials in Houston, United States
- Taipei, Taiwan 8 trialsAll trials in Taipei, Taiwan
- Hangzhou, China 8 trialsAll trials in Hangzhou, China
- Milan, Italy 7 trialsAll trials in Milan, Italy
- Chengdu, China 7 trialsAll trials in Chengdu, China
- Athens, Greece 7 trialsAll trials in Athens, Greece
- Changsha, China 7 trialsAll trials in Changsha, China
- Thessaloníki, Greece 7 trialsAll trials in Thessaloníki, Greece
- Málaga, Spain 6 trialsAll trials in Málaga, Spain
- Montréal, Canada 6 trialsAll trials in Montréal, Canada
- Wuhan, China 6 trialsAll trials in Wuhan, China
- Kashiwa, Japan 6 trialsAll trials in Kashiwa, Japan
- Los Angeles, United States 6 trialsAll trials in Los Angeles, United States
- New York, United States 6 trialsAll trials in New York, United States
- Zhengzhou, China 6 trialsAll trials in Zhengzhou, China
- Seville, Spain 6 trialsAll trials in Seville, Spain